2017 Q3 Form 10-Q Financial Statement

#000131848217000007 Filed on November 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $18.85K $52.76K
YoY Change -64.27% 427.58%
Cost Of Revenue $120.5K
YoY Change 0.42%
Gross Profit $18.85K -$67.75K
YoY Change -127.83% -38.41%
Gross Profit Margin 100.0% -128.41%
Selling, General & Admin $290.0K $190.0K
YoY Change 52.63% -42.42%
% of Gross Profit 1538.22%
Research & Development $194.6K $387.1K
YoY Change -49.73% 29.02%
% of Gross Profit 1032.16%
Depreciation & Amortization $0.00 $120.0K
YoY Change -100.0% 0.0%
% of Gross Profit 0.0%
Operating Expenses $194.6K $387.1K
YoY Change -49.73% -38.56%
Operating Profit -$489.2K -$646.6K
YoY Change -24.34% -12.62%
Interest Expense $10.00K -$10.00K
YoY Change -200.0% -50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$462.7K -$1.156M
YoY Change -59.98% 46.34%
Income Tax $1.00
% Of Pretax Income
Net Earnings -$462.7K -$1.156M
YoY Change -59.98% 46.34%
Net Earnings / Revenue -2454.3% -2191.32%
Basic Earnings Per Share
Diluted Earnings Per Share -$7.412K -$19.48K
COMMON SHARES
Basic Shares Outstanding 62.06M 59.54M
Diluted Shares Outstanding 62.06M 59.54M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $820.0K $80.00K
YoY Change 925.0% -94.16%
Cash & Equivalents $818.1K
Short-Term Investments
Other Short-Term Assets $30.00K $60.00K
YoY Change -50.0% 200.0%
Inventory
Prepaid Expenses $34.11K
Receivables $16.47K $30.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $868.7K $170.0K
YoY Change 410.98% -87.86%
LONG-TERM ASSETS
Property, Plant & Equipment $11.17K $10.00K
YoY Change 11.73% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $10.00K
YoY Change -100.0% 0.0%
Total Long-Term Assets $11.17K $140.0K
YoY Change -92.02% -77.42%
TOTAL ASSETS
Total Short-Term Assets $868.7K $170.0K
Total Long-Term Assets $11.17K $140.0K
Total Assets $879.8K $310.0K
YoY Change 183.82% -84.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.67K $40.00K
YoY Change -45.82% -69.23%
Accrued Expenses $89.50K $80.00K
YoY Change 11.88% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $221.1K $260.0K
YoY Change -14.98% 4.0%
LONG-TERM LIABILITIES
Long-Term Debt $480.0K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $480.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $221.1K $260.0K
Total Long-Term Liabilities $480.0K $0.00
Total Liabilities $701.3K $260.0K
YoY Change 169.72% 4.0%
SHAREHOLDERS EQUITY
Retained Earnings -$22.85M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $178.6K $50.00K
YoY Change
Total Liabilities & Shareholders Equity $879.8K $310.0K
YoY Change 183.82% -84.65%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$462.7K -$1.156M
YoY Change -59.98% 46.34%
Depreciation, Depletion And Amortization $0.00 $120.0K
YoY Change -100.0% 0.0%
Cash From Operating Activities -$430.0K -$120.0K
YoY Change 258.33% -77.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$10.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000M 30.00K
YoY Change 3233.33% -62.5%
NET CHANGE
Cash From Operating Activities -430.0K -120.0K
Cash From Investing Activities 0.000 -10.00K
Cash From Financing Activities 1.000M 30.00K
Net Change In Cash 570.0K -100.0K
YoY Change -670.0% -78.26%
FREE CASH FLOW
Cash From Operating Activities -$430.0K -$120.0K
Capital Expenditures $0.00 -$10.00K
Free Cash Flow -$430.0K -$110.0K
YoY Change 290.91% -79.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 sgldf Accumulated Development Costs
AccumulatedDevelopmentCosts
5541179
CY2016Q3 sgldf Accumulated Development Costs
AccumulatedDevelopmentCosts
4713621
CY2016Q4 sgldf Accumulated Development Costs
AccumulatedDevelopmentCosts
4935274
CY2015Q4 sgldf Accumulated Development Costs
AccumulatedDevelopmentCosts
3857636
CY2017Q2 sgldf Accumulated Development Costs
AccumulatedDevelopmentCosts
5346585
CY2016Q2 sgldf Accumulated Development Costs
AccumulatedDevelopmentCosts
4326553
CY2017Q3 sgldf Amounts Representation By Customer Who Accounted For Greater Than10 Of Total Accounts Receivable
AmountsRepresentationByCustomerWhoAccountedForGreaterThan10OfTotalAccountsReceivable
9691
CY2016Q4 sgldf Amounts Representation By Customer Who Accounted For Greater Than10 Of Total Accounts Receivable
AmountsRepresentationByCustomerWhoAccountedForGreaterThan10OfTotalAccountsReceivable
13300
sgldf Equity Portion Of Promissory Note
EquityPortionOfPromissoryNote
23461
CY2016Q2 sgldf Future Development Expenses
FutureDevelopmentExpenses
863660
sgldf Gain On Extinguishment And Reissuance Of Promissory Notes With Related Party
GainOnExtinguishmentAndReissuanceOfPromissoryNotesWithRelatedParty
94191
sgldf Income Loss On Prepaid Development
IncomeLossOnPrepaidDevelopment
-498791
sgldf Income Loss On Prepaid Development
IncomeLossOnPrepaidDevelopment
CY2017Q3 sgldf Income Loss On Prepaid Development
IncomeLossOnPrepaidDevelopment
CY2016Q3 sgldf Income Loss On Prepaid Development
IncomeLossOnPrepaidDevelopment
-498791
sgldf Interest On Convertible Debt Equity Portion
InterestOnConvertibleDebtEquityPortion
62021
sgldf Interest On Convertible Debt Equity Portion
InterestOnConvertibleDebtEquityPortion
CY2017Q3 sgldf Interest On Convertible Debt Equity Portion
InterestOnConvertibleDebtEquityPortion
22110
CY2016Q3 sgldf Interest On Convertible Debt Equity Portion
InterestOnConvertibleDebtEquityPortion
sgldf Non Cash Financing Activity Discount On Related Party Loans
NonCashFinancingActivityDiscountOnRelatedPartyLoans
23461
sgldf Non Cash Financing Activity Discount On Related Party Loans
NonCashFinancingActivityDiscountOnRelatedPartyLoans
sgldf Non Cash Financing Activity Extinguishment Of Promissory Notes
NonCashFinancingActivityExtinguishmentOfPromissoryNotes
94191
sgldf Non Cash Financing Activity Extinguishment Of Promissory Notes
NonCashFinancingActivityExtinguishmentOfPromissoryNotes
sgldf Noncash Investing Activity
NoncashInvestingActivity
0
sgldf Noncash Investing Activity
NoncashInvestingActivity
0
CY2017Q3 sgldf Prepaid Licenses Fees
PrepaidLicensesFees
19225
CY2016Q4 sgldf Prepaid Licenses Fees
PrepaidLicensesFees
7835
sgldf Warrants Issued In Connection With Common Stock Value Recorded As Derivative Liability
WarrantsIssuedInConnectionWithCommonStockValueRecordedAsDerivativeLiability
123284
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21671
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3667
CY2017Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
44132
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
44860
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16466
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17194
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89502
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87959
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
24580
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
24580
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
27666
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
27666
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27666
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27666
CY2017Q3 us-gaap Assets
Assets
879837
CY2016Q4 us-gaap Assets
Assets
129093
CY2017Q3 us-gaap Assets Current
AssetsCurrent
868664
CY2016Q4 us-gaap Assets Current
AssetsCurrent
110878
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
361510
CY2017Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
CY2016Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
120503
CY2017Q3 us-gaap Cash
Cash
818085
CY2016Q4 us-gaap Cash
Cash
60190
CY2015Q4 us-gaap Cash
Cash
570086
CY2016Q3 us-gaap Cash
Cash
82417
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
757895
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-487669
CY2017Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
612699
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2017Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64919992
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59708318
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64919992
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59708318
CY2017Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
23003127
CY2016Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
21223271
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1285699
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2410934
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-462710
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1156098
us-gaap Cost Of Goods Sold
CostOfGoodsSold
us-gaap Cost Of Goods Sold
CostOfGoodsSold
361510
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
120503
us-gaap Costs And Expenses
CostsAndExpenses
1382408
us-gaap Costs And Expenses
CostsAndExpenses
1760726
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
508086
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15017
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15959
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
578840
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
CY2017Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15959
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
965
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
501
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15017
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
15959
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
15017
CY2017Q3 us-gaap Deposits Assets
DepositsAssets
CY2016Q4 us-gaap Deposits Assets
DepositsAssets
8067
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2615
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1501
CY2017Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
123284
CY2017Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
98615
CY2017Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
98615
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
CY2017Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11276
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5356
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-24669
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-24669
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2861
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-31192
CY2017Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1849
CY2016Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10759
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8
us-gaap Gross Profit
GrossProfit
74888
us-gaap Gross Profit
GrossProfit
-120372
CY2017Q3 us-gaap Gross Profit
GrossProfit
18853
CY2016Q3 us-gaap Gross Profit
GrossProfit
-67745
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1285699
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2410942
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-462710
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1156097
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25467
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
51240
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-728
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15551
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
619
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
40894
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
8067
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-524
us-gaap Interest And Other Income
InterestAndOtherIncome
13
us-gaap Interest And Other Income
InterestAndOtherIncome
139
CY2017Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
5
CY2016Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
38
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
0
CY2017Q3 us-gaap Liabilities
Liabilities
701267
CY2016Q4 us-gaap Liabilities
Liabilities
444680
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
879837
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129093
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
221064
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
96982
CY2017Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
480203
CY2016Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
347698
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1973624
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1539985
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3640
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5104
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1212089
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2022550
us-gaap Net Income Loss
NetIncomeLoss
-1285699
us-gaap Net Income Loss
NetIncomeLoss
-2410934
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-462710
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1156098
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Officers Compensation
OfficersCompensation
2500
us-gaap Officers Compensation
OfficersCompensation
6000
CY2017Q3 us-gaap Officers Compensation
OfficersCompensation
1000
CY2016Q3 us-gaap Officers Compensation
OfficersCompensation
2000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1307520
us-gaap Operating Income Loss
OperatingIncomeLoss
-1881098
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-489233
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-646585
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1486
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4895
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
7669
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
218057
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
186205
CY2017Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
96369
CY2016Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
65601
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3640
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5104
CY2017Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
14888
CY2016Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
25659
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34113
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
33494
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1785488
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1513354
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
188136
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
26631
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11173
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10148
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27666
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
605905
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
855985
CY2017Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
194594
CY2016Q3 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
387068
CY2016Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
332125
CY2016Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
32744
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22849137
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21563438
CY2017Q3 us-gaap Salaries And Wages
SalariesAndWages
121697
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
394389
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
71351
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26044
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1010000
us-gaap Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure
RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"><tr style="vertical-align: top;"><td style="width: 18pt;"></td> <td style="width: 27pt;"> <div style=" margin: 0pt; text-align: left; font-size: 10pt; font-family: Times\ New\ Roman, Times, serif;">(c)</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-size: 10pt; font-family: Times\ New\ Roman, Times, serif;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Revenue recognition:</div></div> </td> </tr> </table> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Trophy Bingo and Garfield's Bing<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">o revenues have been recognized from the sale of in-game purchases, net of platform fees, at the time of purchase by the player. The revenue from in-game advertising is recognized when advertising is served to the player.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Advertising revenues, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">d in Trophy Bingo or Garfield's Bingo, have been recognized when collection of the amounts are reasonably assured.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Rooplay revenues have been recognized when collection of the subscriptions are reasonably assured and the provision of service has occurred.</div></div></div></div></div></div></div></div></div>
us-gaap Revenues
Revenues
74888
us-gaap Revenues
Revenues
241138
CY2017Q3 us-gaap Revenues
Revenues
18853
CY2016Q3 us-gaap Revenues
Revenues
52758
us-gaap Salaries And Wages
SalariesAndWages
339827
us-gaap Salaries And Wages
SalariesAndWages
316646
CY2016Q3 us-gaap Salaries And Wages
SalariesAndWages
97626
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74888
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
241138
CY2017Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
18853
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
52758
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
151483
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
880000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.42
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
130000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
60000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1010000
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.42
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.42
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1785488
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-315587
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
178570
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"><tr style="vertical-align: top;"><td style="width: 27pt;"><div style=" margin: 0pt; text-align: left; font-size: 10pt; font-family: Times\ New\ Roman, Times, serif;">(b)</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-size: 10pt; font-family: Times\ New\ Roman, Times, serif;"><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Use of estimates:</div></div> </td> </tr> </table> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">The pre<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">paration of consolidated financial statements in conformity with US GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and recognized revenues and expenses for the reporting periods. </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Significant areas requiring the use of estimates include the valuation of long-lived assets, the collectibility of accounts receivable, the valuation of promissory <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">notes and the estimated market rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%,</div> the derivative liability - warrants valuation and the valuation of deferred tax assets.&nbsp; Actual results <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>differ significantly from these estimates.</div></div></div></div></div></div></div></div></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60621170
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57737834
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62063832
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59535637
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60621170
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57737834
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62063832
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59535637

Files In Submission

Name View Source Status
0001318482-17-000007-index-headers.html Edgar Link pending
0001318482-17-000007-index.html Edgar Link pending
0001318482-17-000007.txt Edgar Link pending
0001318482-17-000007-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgldf-20170930.xml Edgar Link completed
sgldf-20170930.xsd Edgar Link pending
sgldf-20170930_cal.xml Edgar Link unprocessable
sgldf-20170930_def.xml Edgar Link unprocessable
sgldf-20170930_lab.xml Edgar Link unprocessable
sgldf-20170930_pre.xml Edgar Link unprocessable
sglq317.htm Edgar Link pending
Show.js Edgar Link pending